Related Experiment Video
Updated: Jun 25, 2025

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
Published on: May 4, 2020
Associations Between Genetically Predicted Iron Status and Cardiovascular Disease Risk: A Mendelian Randomization
Alexa Barad1, Andrew G Clark2,3, Eva K Pressman4
1Division of Nutritional Sciences Cornell University Ithaca NY USA.
Insights
Higher iron status increases cardioembolic stroke risk, independent of other cardiovascular disease factors. Diastolic blood pressure partially mediates this association, suggesting iron status is a modifiable risk factor.
Area of Science:
- Cardiovascular Epidemiology
- Genetic Epidemiology
- Iron Metabolism
Background:
- Mendelian randomization (MR) studies suggest iron status influences cardiovascular disease (CVD) risk.
- Potential confounding by pleiotropic effects of instrumental variables on CVD risk factors requires investigation.
Purpose of the Study:
- To investigate the effect of iron status on CVD risk, controlling for established CVD risk factors.
- To assess potential confounding or mediating effects of CVD risk factors on the iron-CVD association.
Main Methods:
- Two-sample univariate and multivariate Mendelian randomization (MR) analyses were performed.
- Instrumental variables for iron biomarkers (total iron-binding capacity, transferrin saturation, serum iron, ferritin) were used.
- Associations with CVD outcomes (stroke subtypes, coronary heart disease) were examined, adjusting for 7 CVD risk factors.
Main Results:
- Higher genetically predicted iron status was associated with increased cardioembolic ischemic stroke risk (e.g., transferrin saturation OR 1.17, serum iron OR 1.21).
- These detrimental effects on cardioembolic stroke risk persisted after adjusting for CVD risk factors.
- Diastolic blood pressure partially mediated the effect of iron status on cardioembolic stroke.
- Apparent protective effects of iron status on large-artery stroke and coronary heart disease were diminished after multivariate adjustment.
Conclusions:
- Elevated iron status is linked to a higher risk of cardioembolic ischemic stroke, independent of other CVD risk factors.
- Diastolic blood pressure plays a partial mediating role in this association.
- Iron status represents a potential modifiable risk factor for cardioembolic ischemic stroke.
Background:
Mendelian randomization (MR) studies suggest a causal effect of iron status on cardiovascular disease (CVD) risk, but it is unknown if these associations are confounded by pleiotropic effects of the instrumental variables on CVD risk factors. We aimed to investigate the effect of iron status on CVD risk controlling for CVD risk factors.
Methods And Results:
Iron biomarker instrumental variables (total iron-binding capacity [n=208 422], transferrin saturation [n=198 516], serum iron [n=236 612], ferritin [n=257 953]) were selected from a European genome-wide association study meta-analysis. We performed 2-sample univariate MR of each iron trait on CVD outcomes (all-cause ischemic stroke, cardioembolic ischemic stroke, large-artery ischemic stroke, small-vessel ischemic stroke, and coronary heart disease) from MEGASTROKE (n=440 328) and CARDIoGRAMplusC4D (Coronary Artery Disease Genome Wide Replication and Meta-Analysis Plus the Coronary Artery Disease Genetics) (n=183 305). We then implemented multivariate MR conditioning on 7 CVD risk factors from independent European samples to evaluate their potential confounding or mediating effects on the observed iron-CVD associations. With univariate MR analyses, we found higher genetically predicted iron status to be associated with a greater risk of cardioembolic ischemic stroke (transferrin saturation: odds ratio, 1.17 [95% CI, 1.03-1.33]; serum iron: odds ratio, 1.21 [95% CI, 1.02-1.44]; total iron-binding capacity: odds ratio, 0.81 [95% CI, 0.69-0.94]). The detrimental effects of iron status on cardioembolic ischemic stroke risk remained unaffected when adjusting for CVD risk factors (all P<0.05). Additionally, we found diastolic blood pressure to mediate between 7.1 and 8.8% of the total effect of iron status on cardioembolic ischemic stroke incidence. Univariate MR initially suggested a protective effect of iron status on large-artery stroke and coronary heart disease, but controlling for CVD factors using multivariate MR substantially diminished these associations (all P>0.05).
Conclusions:
Higher iron status was associated with a greater risk of cardioembolic ischemic stroke independent of CVD risk factors, and this effect was partly mediated by diastolic blood pressure. These findings support a role of iron status as a modifiable risk factor for cardioembolic ischemic stroke.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

